Covered recipient · General Payments record
HESHAM A ELMERGAWY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2021–2024
$879.81
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $463.81 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $175.97 | 4 |
| ABBVIE INC. | $55.63 | 2 |
| Amgen Inc. | $46.01 | 2 |
| Genentech USA, Inc. | $30.95 | 1 |
| Mallinckrodt Hospital Products Inc. | $26.56 | 1 |
| Janssen Biotech, Inc. | $26.20 | 1 |
| GlaxoSmithKline, LLC. | $25.79 | 1 |
| Aurinia Pharma U.S., Inc. | $24.83 | 1 |
| Fresenius Kabi USA, LLC | $22.18 | 1 |
| Organon LLC | $15.64 | 1 |
| PFIZER INC. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.89 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689340 | CMS |
| ABBVIE INC. | $25.74 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689342 | CMS |
| Amgen Inc. | $22.32 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111569687 | CMS |
| Amgen Inc. | $23.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111569689 | CMS |
| Aurinia Pharma U.S., Inc. | $24.83 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150679679 | CMS |
| Fresenius Kabi USA, LLC | $22.18 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146945695 | CMS |
| Genentech USA, Inc. | $30.95 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133020583 | CMS |
| GlaxoSmithKline, LLC. | $25.79 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116273838 | CMS |
| Janssen Biotech, Inc. | $26.20 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078580892 | CMS |
| Mallinckrodt Hospital Products Inc. | $26.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145068577 | CMS |
| Organon Llc | $15.64 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136200941 | CMS |
| PFIZER INC. | $14.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132038118 | CMS |
| UCB, Inc. | $124.83 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143272554 | CMS |
| UCB, Inc. | $6.26 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143272558 | CMS |
| UCB, Inc. | $24.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143272562 | CMS |
| UCB, Inc. | $20.02 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143272566 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.